{
  "ticker": "RMD",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02965394",
  "id": "02965394",
  "pages": 3,
  "price_sensitive": false,
  "date": "20250703",
  "time": "0821",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250703/pdf/06ldvrkxhp9shx.pdf",
  "summary": "- **Form 144 Filing (Insider Sale):**  \n  - **Insider:** Peter C. Farrell (Director of ResMed Inc.)  \n  - **Securities to be Sold:** 945 shares of Common Stock  \n  - **Aggregate Market Value:** $250,000  \n  - **Approximate Sale Date:** 02-Jul-2025 (NYSE)  \n  - **Recent Sales (Past 3 Months):**  \n    - 02-Apr-2025: 2,000 shares ($439,406.75 proceeds)  \n    - 07-May-2025: 2,000 shares ($484,406.53 proceeds)  \n    - 04-Jun-2025: 2,000 shares ($494,560.00 proceeds)  \n  - **Rule 10b5-1 Plan:** Plan adopted on 28-May-2024 (prearranged trading).  \n\n**Relevance:** Signals potential increase in near-term selling pressure. Note planned nature of sales (less material than unplanned disposals).",
  "usage": {
    "prompt_tokens": 1340,
    "completion_tokens": 218,
    "total_tokens": 1558,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-02T22:37:23.742968"
}